| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $800K | — | +0.0% |
| R&D Expense | $6.0M | — | +60.5% |
| SG&A Expense | $6.1M | — | +8.4% |
| Operating Income | -$12.1M | — | -11.9% |
| Pre-tax Income | -$10.6M | — | -23.5% |
| Income Tax | $10K | — | -64.3% |
| Net Income | -$10.6M | — | -23.2% |
| EPS (Basic) | -$0.95 | — | -427.8% |
| EPS (Diluted) | -$0.95 | — | -427.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $76.0M | -19.6% | +106.9% |
| Short-term Investments | $41.2M | +0.8% | -46.7% |
| Current Assets | $122.0M | -13.0% | +4.3% |
| Total Assets | $136.7M | -10.7% | +4.5% |
| Current Liabilities | $6.6M | -40.9% | -24.6% |
| Total Liabilities | $13.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.8M | — | -40.1% |
| Investing Cash Flow | -$440K | — | -105.5% |
| Financing Cash Flow | -$3.2M | — | — |
| +6.1% |
| Stockholders' Equity | $123.3M | -7.4% | +4.3% |